The Rapidly Emerging Antiviral Drug Development Initiative is retooling the drug discovery and development process to rapidly develop new antiviral drug solutions for the future. These pandemics are bigger than any one company, government or academy. A unique public-private partnership accelerated by open science, READDI has a goal of developing multiple “on the shelf” clinical assets so we are prepared for the next global health pandemic.

READDI brings together leaders from industry, government, philanthropic organizations, and academic research institutions to leverage existing platforms and accelerate the development of new antiviral drugs.

READDI

Org chart

Teams

Offices